<bill session="106" type="h" number="805" updated="2013-07-14T18:53:10-04:00">
  <state datetime="1999-02-23">REFERRED</state>
  <status>
    <introduced datetime="1999-02-23"/>
  </status>
  <introduced datetime="1999-02-23"/>
  <titles>
    <title as="introduced" type="short">Generic Drugs Access Act of 1999</title>
    <title as="introduced" type="official">To amend the Federal Food, Drug, and Cosmetic Act to establish therapeutic equivalence requirements for generic drugs, and for other purposes.</title>
  </titles>
  <sponsor id="400308"/>
  <cosponsors>
    <cosponsor id="400007" joined="1999-02-23"/>
    <cosponsor id="400026" joined="1999-02-23"/>
    <cosponsor id="400050" joined="1999-02-23"/>
    <cosponsor id="400063" joined="1999-04-28"/>
    <cosponsor id="400532" joined="1999-02-23"/>
    <cosponsor id="400106" joined="1999-03-03"/>
    <cosponsor id="400128" joined="1999-03-03"/>
    <cosponsor id="400178" joined="1999-02-23"/>
    <cosponsor id="400199" joined="1999-02-23"/>
    <cosponsor id="400215" joined="1999-03-03"/>
    <cosponsor id="400217" joined="1999-02-23"/>
    <cosponsor id="400529" joined="1999-02-23"/>
    <cosponsor id="400600" joined="1999-02-23"/>
    <cosponsor id="400289" joined="1999-02-23"/>
    <cosponsor id="400295" joined="1999-02-23"/>
    <cosponsor id="400333" joined="1999-02-23"/>
    <cosponsor id="400358" joined="1999-03-03"/>
    <cosponsor id="400360" joined="1999-02-23"/>
    <cosponsor id="400530" joined="1999-02-23"/>
    <cosponsor id="400383" joined="1999-04-15"/>
    <cosponsor id="400387" joined="1999-02-23"/>
    <cosponsor id="400425" joined="1999-02-23"/>
    <cosponsor id="400426" joined="1999-02-23"/>
  </cosponsors>
  <actions>
    <action datetime="1999-02-23">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E263"/>
    </action>
    <action state="REFERRED" datetime="1999-02-23">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="1999-03-11">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Communication in medicine"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Federal preemption"/>
    <term name="Generic drugs"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Law"/>
    <term name="Local laws"/>
    <term name="State laws"/>
  </subjects>
  <amendments/>
  <summary>2/23/1999--Introduced.
Generic Drugs Access Act of 1999 - Amends the Federal Food, Drug, and Cosmetic Act with respect to new drug applications to direct the Secretary of Health and Human Services to include in an application approval a finding about whether the approved (generic) drug is the therapeutic equivalent of the listed drug involved. Prohibits a State or its political subdivision from establishing or continuing any requirement that does not conform to the therapeutic equivalence requirement of this Act.</summary>
</bill>
